ReposiTrak (TRAK) Research & Development (2010 - 2025)

ReposiTrak has reported Research & Development for 16 years, with the latest figure at $1.5 million in Q4 2025.

• On a quarterly basis, Research & Development rose 2.7% year-over-year to $1.5 million in Q4 2025; TTM through Dec 2025 was $6.0 million, a 4.45% increase from a year earlier, with the FY2025 full-year figure at $5.8 million, up 6.38% from the prior year.
• Research & Development was $1.5 million for Q4 2025 at ReposiTrak, down from $1.6 million in the prior quarter.
• The five-year high for Research & Development was $1.6 million in Q3 2025, with the low at $1.2 million in Q4 2021.
• Average Research & Development over 5 years is $1.3 million, with a median of $1.3 million recorded in 2022.
• The sharpest annual moves came in 2021 and 2023: Research & Development slumped 30.16% in 2021, then rose 25.43% in 2023.
• Over 5 years, Research & Development stood at $1.2 million in 2021, then gained by 6.49% to $1.2 million in 2022, then gained by 3.06% to $1.3 million in 2023, then rose by 15.08% to $1.5 million in 2024, then grew by 2.7% to $1.5 million in 2025.
• The last three Research & Development figures came in at $1.5 million (Q4 2025), $1.6 million (Q3 2025), and $1.5 million (Q2 2025), per Business Quant data.